Profile of gyrA gene mutation in clinical isolate of levofloxacin resistant Escherichia coli

J Basic Clin Physiol Pharmacol. 2021 Jun 25;32(4):751-754. doi: 10.1515/jbcpp-2020-0445.

Abstract

Objectives: Escherichia coli is one of the pathogenic bacteria that caused a nosocomial infection. Levofloxacin is one of the fluoroquinolones group antibiotics which is a broad-spectrum antibiotic that works effectively against E. coli. The mutation can happen in the bacteria which caused a resistant effect in the use of antibacterial. This study aimed at identifying mutation in gene gyrA among E. coli that were resistant to levofloxacin.

Methods: The susceptibility of E . coli was determined by disk diffusion. PCR and sequencing were performed to identify the mutation in gyrA.

Results: A total of 10 isolates showed result resistance to levofloxacin and gyrA gene mutation in the amino acid changes. Nucleotide sequence analysis revealed a point mutation in QRDR (quinolone resistance determining region) of gyrA Ser83→Leu, Asp87→Asn. The silent mutation was also found at codon Val85, Arg91, Ser111, Thr123.

Conclusions: Mutation in the gyrA gene affect the occurrence of bacterial resistance of E. coli to levofloxacin.

Keywords: Escherichia coli; codon; gyrA; levofloxacin; mutation.

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • DNA Gyrase / genetics
  • DNA Topoisomerase IV / genetics
  • Escherichia coli* / genetics
  • Fluoroquinolones / pharmacology
  • Levofloxacin* / pharmacology
  • Microbial Sensitivity Tests
  • Mutation

Substances

  • Anti-Bacterial Agents
  • Fluoroquinolones
  • Levofloxacin
  • DNA Topoisomerase IV
  • DNA Gyrase